Thalidomide does not improve survival in lung cancer

by Anil Kumar



Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, revealed by researchers.

The new study is published in the Journal of the National Cancer Institute.

Siow Ming Lee, M.D., of the Department of Oncology, University Hospital in London, and colleagues randomly assigned 724 SCLC patients to take either a placebo or thalidomide. Used in treating some other cancers, thalidomide is an anti-angiogenic drug, i.e., it targets and suppresses the formation of new blood vessels that tumors need to survive and grow. In this randomized double-blind trial, patients received 100-200 milligrams daily for up to two years.

The researchers found no evidence of a survival difference between the two groups. The median overall survival for patients who received the placebo was 10.5 months. For patients who took thalidomide capsules, it was 10.1 months. Patients treated with thalidomide, however, had higher risk of thrombotic events.

"Together, these results suggest that targeting anti-angiogenesis in SCLC may not work as well as in multiple myeloma or colorectal cancer, perhaps because of differences in the angiogenic pathways involved in SCLC," the authors write.

In an accompanying editorial, Curzio Rüegg, M.D., of the Division of Experimental Oncology at the University of Lausanne in Switzerland, and Solange Peters, M.D., Ph.D., of the Clinical Oncology Service at the University of Lausanne, note that this study's results, as well as similar, negative results from previous studies, should lead to a fresh look at the basic biology of SCLC and of the putative anti-angiogenic activity of thalidomide.

"Rather than running from failure to failure, it may be more reasonable to go back to experimental work, including the development and analysis of transgenic SCLC models, to better understand SCLC biology and identify robust therapeutic targets," the editorialists write.


(Anil Kumar -- sub-editor compiled and published Thalidomide does not improve survival in lung cancer at HealthNewsTrack on July 19, 2009 sourced from Journal of the National Cancer Institute - http://jncicancerspectrum.oupjournals.org/)

Lung Cancer - recent articles and current news stories:

- New lung cancer test could accurately guide treatment for people with lung cancer
- 20% reduction in lung cancer mortality with low dose CT vs chest X ray
- Gene expression changes in nasal cells may help identify lung cancer
- Genetic test for lung cancer risk prompts smokers to quit
- Vitamin B6 lowers risk of lung cancer

Lung Cancer article/news source:

Read more health articles from Journal of the National Cancer Institute and health articles from UK.

Lung Cancer - search related terms:

Anti angiogenic, Blood clot, Cancer, Chemotherapy, Lung cancer, Oncology, Small cell lung cancer, Survival, Thalidomide, Thrombotic,
Lung Cancer books,

Searched keywords: lung cancer (42), lungs (8), small cell lung cancer (7),

Subscribe to Health News by Email

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
0.93